News
Investors
Contact
Home
About
Overview
Management Team
Board of Directors
Quality Management System
Sustainability
Technologies
Overview
Ethanol Fractionation Processes
Pressurized Gas Expanded (PGX) Technology
Chromatography Purification
Intellectual Property
Scientific Publications
Pipeline
Overview
Oat Beta Glucan
Avenanthramides
Product Brochures
Cosmeceuticals
Overview
Nutraceuticals
Overview
Oat Beta Glucan
Avenanthramides
Business Development
Overview
Partners
News
Investors
Contact
Home
News
Media Coverage
CEO Interview
CEO Interview
January 22, 2019
Gilles Gagnon, CEO of Ceapro provides Company overview and discusses how Ceapro is working on commercializing the "active ingredients" derived from oats and other renewable plant resources for healthcare and cosmetic industries.